First Trust Advisors LP Neurocrine Biosciences Inc Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, First Trust Advisors LP holds 544,321 shares of NBIX stock, worth $73.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

544,321

Previous 433,537 25.55%

Holding current value

$73.7 Million

Previous $59.7 Million 5.0%

% of portfolio

0.06%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$114.58 - $153.15 $12.7 Million - $17 Million	110,784 Added 25.55%	544,321 $62.7 Million
Q2 2024 Aug 13, 2024	SELL	$130.86 - $143.19 $12.2 Million - $13.3 Million	-93,045 Reduced 17.67%	433,537 $59.7 Million
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $8.36 Million - $9.22 Million	-64,143 Reduced 10.86%	526,582 $72.6 Million
Q4 2023 Feb 13, 2024	BUY	$106.07 - $132.76 $13.5 Million - $16.9 Million	127,085 Added 27.41%	590,725 $77.8 Million
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $6.32 Million - $7.87 Million	-67,244 Reduced 12.67%	463,640 $52.2 Million
Q2 2023 Aug 14, 2023	SELL	$89.53 - $104.87 $12.8 Million - $15 Million	-143,132 Reduced 21.24%	530,884 $50.1 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $28,044 - $36,659	298 Added 0.04%	674,016 $68.2 Million
Q4 2022 Feb 09, 2023	SELL	$106.72 - $127.06 $9.72 Million - $11.6 Million	-91,049 Reduced 11.91%	673,718 $80.5 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $17.8 Million - $20.8 Million	193,015 Added 33.76%	764,767 $81.2 Million
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $5.21 Million - $6.88 Million	-68,707 Reduced 10.73%	571,752 $55.7 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $3.15 Million - $4.12 Million	43,447 Added 7.28%	640,459 $60 Million
Q4 2021 Feb 08, 2022	SELL	$79.65 - $106.22 $6.47 Million - $8.63 Million	-81,261 Reduced 11.98%	597,012 $50.8 Million
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $2.65 Million - $3.04 Million	30,718 Added 4.74%	678,273 $65.1 Million
Q2 2021 Aug 16, 2021	SELL	$89.43 - $102.27 $576,912 - $659,743	-6,451 Reduced 0.99%	647,555 $63 Million
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $1.4 Million - $1.9 Million	15,949 Added 2.5%	654,006 $63.6 Million
Q4 2020 Feb 02, 2021	SELL	$86.91 - $108.33 $17.9 Million - $22.3 Million	-206,232 Reduced 24.43%	638,057 $61.2 Million
Q3 2020 Nov 05, 2020	SELL	$96.16 - $135.15 $1.23 Million - $1.72 Million	-12,747 Reduced 1.49%	844,289 $81.2 Million
Q2 2020 Jul 22, 2020	SELL	$85.09 - $130.36 $6.92 Million - $10.6 Million	-81,342 Reduced 8.67%	857,036 $105 Million
Q1 2020 May 06, 2020	BUY	$75.11 - $113.76 $22.2 Million - $33.7 Million	296,167 Added 46.12%	938,378 $81.2 Million
Q4 2019 Feb 03, 2020	SELL	$86.8 - $118.57 $6.8 Million - $9.3 Million	-78,397 Reduced 10.88%	642,211 $69 Million
Q3 2019 Nov 04, 2019	SELL	$83.82 - $101.5 $46.7 Million - $56.5 Million	-557,092 Reduced 43.6%	720,608 $64.9 Million
Q2 2019 Jul 30, 2019	BUY	$72.24 - $91.27 $14.1 Million - $17.8 Million	194,643 Added 17.97%	1,277,700 $108 Million
Q1 2019 May 09, 2019	SELL	$69.31 - $91.53 $15 Million - $19.8 Million	-216,398 Reduced 16.65%	1,083,057 $95.4 Million
Q4 2018 Feb 07, 2019	BUY	$68.32 - $124.36 $19 Million - $34.6 Million	278,598 Added 27.29%	1,299,455 $92.8 Million
Q3 2018 Oct 25, 2018	BUY	$98.88 - $125.85 $4.07 Million - $5.18 Million	41,186 Added 4.2%	1,020,857 $126 Million
Q2 2018 Aug 02, 2018	BUY	$75.3 - $105.99 $3.93 Million - $5.53 Million	52,200 Added 5.63%	979,671 $96.2 Million
Q1 2018 Apr 23, 2018	BUY	$75.88 - $92.43 $5.66 Million - $6.9 Million	74,636 Added 8.75%	927,471 $76.9 Million
Q4 2017 Feb 08, 2018	BUY	$58.53 - $77.59 $4.11 Million - $5.44 Million	70,150 Added 8.96%	852,835 $66.2 Million
Q3 2017 Oct 24, 2017	BUY	$47.97 - $61.28 $37.5 Million - $48 Million	782,685	782,685 $48 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Neurocrine Biosciences Inc Transaction History